lovastatin has been researched along with Cystic Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Corey, DA; Kelley, TJ; Kraynack, NC; Kreiselmeier, NE | 1 |
2 other study(ies) available for lovastatin and Cystic Fibrosis
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Anticholesteremic Agents; Cell Line, Tumor; Cholesterol; Cystic Fibrosis; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Humans; Lovastatin; Lung Neoplasms; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Inhibitors of Activated STAT; Proteins; Respiratory Mucosa; rhoA GTP-Binding Protein; Signal Transduction; STAT1 Transcription Factor; Terpenes; Trans-Activators | 2003 |